Medical News

RSS

Omeros initiates enrollment in OMS302 Phase 2b clinical trial in patients undergoing cataract surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.

27 Jul 2010

Addus HomeCare acquires operations, certain assets of Advantage Health Systems

Addus HomeCare Corporation, a provider of comprehensive in-home social and medical services, announced today the acquisition of the operations and certain assets of Advantage Health Systems, Inc., which provides these services in South Carolina and Georgia.

27 Jul 2010

Momenta Pharmaceuticals provides update on generic Lovenox ANDA litigation

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today provided an update regarding a lawsuit that Sanofi-Aventis U.S. LLC filed in the United States District Court for the District of Columbia against the U.S. Food and Drug Administration (FDA), Margaret A. Hamburg, Commissioner of Food and Drugs, and Kathleen Sebelius, Secretary of Health and Human Services.

27 Jul 2010

First Edition: July 27, 2010

Today's health policy news includes reports about the continuing Senate backlash to Dr. Donald Berwick's appointment to head the Center for Medicare and Medicaid Services as well as findings from a new poll that reveal seniors really don't understand health reform.

27 Jul 2010

Progenra receives Official Notice of Allowance for screening platform

Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.

27 Jul 2010

Process improvement program improves adherence to evidence-based CRT, ICD and drug therapy

Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.

27 Jul 2010

Age-in Study 2010 shows how age 65 has become irrelevant to boomers' retirement plans

Leading boomers (aged 63-64) want to continue working, but three times as many are unemployed today as were two years ago. They face high unemployment, unwanted early retirement, and early draws on Social Security, meaning less retirement income. This critical finding is from Deft Research's just-released Age-in Study 2010.

27 Jul 2010

Thermo Fisher Scientific highlights products, services for clinical research and specialty diagnostics at AACC 2010

Thermo Fisher Scientific Inc., the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.

From Thermo Fisher Scientific Inc. 27 Jul 2010

Studies that compare treatment options for carotid artery disease provide no clear answer, physician reports

A review of scientific studies that compares two treatments for preventing strokes due carotid artery disease provides no clear answer on which treatment is better, a UT Southwestern Medical Center physician reports in an editorial in today's issue of the Archives of Internal Medicine.

27 Jul 2010

Kinetic Concepts second-quarter global revenue increases 1% to $497.8 million

Kinetic Concepts, Inc. today reported second quarter 2010 total revenue of $497.8 million, an increase of 1% from the second quarter of 2009 and up 2% from the first quarter of 2010. Total revenue for the first half of 2010 was $983.6 million, a 2% increase from the prior-year period. Unfavorable foreign currency exchange movements reduced total revenue for the second quarter of 2010 by less than 1%, while favorably impacting total revenue for the first six months of 2010 by 1% compared to the corresponding periods of the prior year.

27 Jul 2010

Journal of Mental Health features special issue on diagnosing mental illness

This month Journal of Mental Health features a special issue on diagnosing mental illness. The issue - which comes out just weeks after the eagerly-awaited new draft of the Diagnostic and Statistical Manual of Mental Disorders, the global diagnostic 'bible' for the field of mental health medicine - includes a series of articles written by high profile mainstream personalities on what a diagnosis of mental illness has meant to them.

27 Jul 2010

Centene second-quarter premium and service revenues increase 12.8% to $1.051 billion

Centene Corporation today announced net earnings from continuing operations for the quarter ended June 30, 2010, of $23.0 million, or $0.45 per diluted share.

27 Jul 2010

ICON second-quarter 2010 net revenues increase 2% to $224 million

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2010.

27 Jul 2010

BK Medical appointed as sole agent for AMD's Prostate HistoScanning in UK

Advanced Medical Diagnostics SA, a privately held company committed to providing innovative computer-aided solutions (HistoScanning™) that can improve the diagnostic interpretation of ultrasound scans, today announced that it has appointed BK Medical UK Ltd as sole agent for Prostate HistoScanning™ in the UK.

27 Jul 2010

SeeChange Health Insurance to offer value-based HSA products to California employers

SeeChange Health Insurance Company, a provider of value-based health insurance plans to employers, will offer a variety of Health Savings Account products in parts of California beginning August 1, 2010. The product launch will make SeeChange Health the first insurance company to offer value-based HSA products to California employers.

27 Jul 2010

Encision reports 8% decline in first-quarter fiscal 2011 net sales

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its first fiscal quarter ended June 30, 2010.

27 Jul 2010

Rockport adds 25,000 OptumHealth physical medicine specialists to workers' compensation PPO network

Rockport Healthcare Group announced it is adding more than 25,000 OptumHealth physical medicine specialists to its workers' compensation Preferred Provider Organization (PPO) network. The PPO program launched May 1, 2010.

27 Jul 2010

Haiti: might the earthquake worsen TB rates?

Prior to the earthquake of January 12th 2010, Haiti had experienced the highest TB notification rate in the Latin America and Caribbean region. In a forthcoming editorial in Expert Review of Respiratory Medicine, Kevin Schwartzman and colleagues from the McGill University Health Centre (Montreal, Canada) discuss whether the devastation of Haiti six months ago will lead to an unavoidable increase in the incidence of TB.

27 Jul 2010

Cardiac Science introduces Quinton 9500 Series cardiac stress systems

Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, today announced the introduction of two new products that extend its market-leading position in the cardiac stress test category.

27 Jul 2010

Article One completes $5 million institutional funding round with Alleghany Capital

Article One Partners, the world's largest patent research community, today announced the completion of a $5 million round of institutional funding with Alleghany Capital Corporation, a subsidiary of Alleghany Corporation, and other investors. The funding will be used to further consolidate the firm's leading position in the global online patent validation sector by enhancing existing products and services, developing new ones and accelerating sales.

27 Jul 2010

Medical News

Omeros initiates enrollment in OMS302 Phase 2b clinical trial in patients undergoing cataract surgery

Addus HomeCare acquires operations, certain assets of Advantage Health Systems

Momenta Pharmaceuticals provides update on generic Lovenox ANDA litigation

First Edition: July 27, 2010

Progenra receives Official Notice of Allowance for screening platform

Process improvement program improves adherence to evidence-based CRT, ICD and drug therapy

Age-in Study 2010 shows how age 65 has become irrelevant to boomers' retirement plans

Thermo Fisher Scientific highlights products, services for clinical research and specialty diagnostics at AACC 2010

Studies that compare treatment options for carotid artery disease provide no clear answer, physician reports

Kinetic Concepts second-quarter global revenue increases 1% to $497.8 million

Journal of Mental Health features special issue on diagnosing mental illness

Centene second-quarter premium and service revenues increase 12.8% to $1.051 billion

ICON second-quarter 2010 net revenues increase 2% to $224 million

BK Medical appointed as sole agent for AMD's Prostate HistoScanning in UK

SeeChange Health Insurance to offer value-based HSA products to California employers

Encision reports 8% decline in first-quarter fiscal 2011 net sales

Rockport adds 25,000 OptumHealth physical medicine specialists to workers' compensation PPO network

Haiti: might the earthquake worsen TB rates?

Cardiac Science introduces Quinton 9500 Series cardiac stress systems

Article One completes $5 million institutional funding round with Alleghany Capital

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News